Survival of patients with metastatic pancreatic cancer undergoing biliary drainage

Abstract

Pancreatic cancer is one of the most lethal neoplasms in the world, with a high incidence, ranking fourth in the total number of cancer-related deaths, and in Brazil, it is responsible for 2% of all types of cancer and 4% of the total deaths from this disease. It affects patients of both genders. The association of new less invasive techniques such as biliary drainage in patients with pancreatic cancer helps in the treatment of the disease, thus increasing their quality of life and survival, with very low complication rates. This study sought to identify in the literature the survival of patients with metastatic pancreatic cancer undergoing biliary drainage. It was carried out through a bibliographic review, in the Scielo and Lilacs databases, in the period between 2009 and 2017. The average survival of patients with advanced stage pancreatic cancer is around six to eleven months, and in Literature has shown that, in relation to endoscopic biliary drainage, there is a decrease in bilirubin levels, improving the social and psychological function of the patient. In the literature review, it was evident that the statistically significant factor related to greater survival is related to the greater number of chemotherapy lines received.